Pharmaceuticals

A Renewed Sense of Hope: Roche's Ocrevus Continues to Impress in MS Care

A Collective Sigh of Relief: Health Minister Confirms Robust Medicine Supplies for Months Ahead

The Audacious Pivot: How Kelonia Rose from the Brink to a $3 Billion Gene Therapy Vision

A Digital Pioneer Departs: Andrew Baum's Exit from Pfizer

The Psychedelic Crossroads: Hope, Science, and the Shadow of Politics

Lilly's Strategic Gambit: Unpacking the Kelonia Therapeutics Partnership

Pharma's Next Leap: Novo Nordisk and OpenAI Forge AI Alliance

Biocon's Bold Vision: Charting a Course for Global Insulin Leadership

The Biotech Tango: Why Merck Pumped the Brakes on Terns Pharmaceuticals' Acquisition

The Unraveling of Kezar Life Sciences: How an FDA Delay Triggered a Biotech Startup's Collapse

The Unspoken Irony: RFK Jr.'s Medical Freedom Paradox

Takeda Announces Significant Job Cuts, Centered on Cambridge R&D

GLP-1 Drugs: The Unexpected Battle Against Addiction

Closing Bell Insights: Navigating Pfizer, Agribusiness, and Gold Miners as the Market Winds Down

Essential Medicines: DRAP Dispels Price Hike Rumors Amid Global Uncertainty

Eli Lilly's Cancer Revolution: How Loxo Oncology Reshaped an Empire

The Unforeseen Ripple: How Trump's Drug Pricing Push Could Have Raised Global Costs

India's Rupee Hits New Low: A Double-Edged Sword for the Economy

Deepening Roots: India's Manufacturing Dreams and Global Pharma's Embrace

When Geopolitics Hits Home: The Unsettling Shadow of an Iran Conflict on Our Medicine Cabinet

The Gene Therapy Race: Is America Losing Ground to China's Rapid Advance?

Eli Lilly's Retatrutide Triumphs in Key Diabetes Trial, Poised to Reshape Obesity Treatment Landscape

The Dawn of a New Era: Accessible Obesity Treatment for All

The Persistent Echo: Trump's Most Favored Nation Policy Still Shapes Drug Pricing Debates

Five Crucial Stocks to Watch as We Kick Off the Trading Week

The Shadow Side of Breakthroughs: A Tragic Ozempic Lawsuit Unveils Concerns Over Patient Safety

A Glimmer of Hope for Kidney Disease: Vertex's Breakthrough in IgA Nephropathy

Olema Pharmaceuticals Stock Takes a Dive: What Sparked the Sudden Plunge?

The FDA's Quiet Retreat: Fewer Public Debates Amid Rising Controversy

A Critical Voice Departs: Dr. Vinay Prasad's Resignation From FDA Advisory Role

The Price of Life: Will South Africa Gain Access to Gilead's Breakthrough HIV Drug?

The Persistent Ache: Why Affordable Drug Prices Remain an Elusive Dream for Americans

Virginia's Bold Move: A New Era for Prescription Drug Affordability

A Major Setback: FDA Halts uniQure's Huntington's Gene Therapy Trial

GSK's Bold Move: A $1.8 Billion Bet on the Future of Pulmonary Hypertension Treatment

The Final Word: Navigating Pharma's Powerhouse and Gold's Gleam in Today's Markets

A New Chapter Unfolds: India and Brazil Forge Stronger Ties, Eyeing Critical Minerals and a Bilateral Trade Boom

Is India-US Trade Deal a 'Trap'? Kharge Demands Transparency on Critical Agreement

Why Barclays Still Sees Eli Lilly as the Undisputed Champion in the Exploding GLP-1 Arena, Even as Rivals Crowd In